KRAS and malignant colon neoplasm: Moreover, GM-CSF protein and mRNA levels were significantly higher in K-ras positive, stage D patients (P<0.001) (Figure 2A–B) compared to K-ras negative and healthy control patients, indicating an induced GM-CSF activation during colon cancer stage progression tumorigenesis (Figure 4A, Figure S1).